A new isotope production system has been installed in Unit 6 of the Bruce nuclear power station in Ontario, Canada, which will significantly increase the production capacity of lutetium-177 (Lu-177), a cancer-fighting medical isotope. The initiative ensures a stable supply during scheduled outages and demonstrates Bruce Power's commitment to leveraging its Candu technology in medical isotope production. Federal Energy Minister Tim Hodgson announced the system's installation, highlighting Canada's potential as a leader in the isotope sector. Lu-177, used in targeted radionuclide therapy for prostate cancer, offers precision in treating diseased cells while preserving healthy tissue, providing hope to patients globally.
Wed, 20 Aug 2025 14:26:52 GMT | NucNet